Origin Therapeutics Announces Closing Of Safe Supply Subscription Receipt Financing
08/02/23, 4:00 PM
Location
cambridgeIndustry
manufacturing
Origin Therapeutics Holdings Inc. (“Origin” or the “Company”) is pleased to announce the closing of a private placement offering (the “Offering”) of 5,965,000 subscription receipts (“Subscription Receipts”) of Safe Supply Streaming Co. Ltd. (“Safe Supply”) at a price of $0.40 per Subscription Receipt for aggregate gross proceeds of approximately $2,386,000.
Company Info
Location
cambridge, maryland, united states
Additional Info
Origin is advancing the BEAK, a man-portable ISR (Intelligence, Surveillance, and Reconnaissance) drone-launched precision-guided weapon system. The BEAK employs advanced computer-vision algorithms and AI for precision guidance technology and autonomous flight, allowing it to navigate complex environments and respond to threats even under intense radio jamming. In addition to these capabilities, the BEAK is man-portable, quick to deploy, and designed for ease of use, making it desirable for defence forces operating in rapidly changing environments.